Advanced Biomed Growth Metrics (2024-2026) | ADVB

Growth Metrics Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
Assets Growth (1y) (Quarter) 207.56%140.90%28.46%
Assets (QoQ) (Quarter) 84.00%65.52%-54.49%73.81%-1.88%
Capital Expenditures Growth (1y) (Quarter) 108.30%-62.17%-91.14%220.71%-42.93%
Capital Expenditures (QoQ) (Quarter) 299.47%-62.49%-153.52%120.72%809.66%-91.21%628.74%-90.21%
Cash & Equivalents Growth (1y) (Quarter) -4.64%19.25%11.35%0.36%-1.62%-18.06%
Cash & Equivalents (QoQ) (Quarter) -4.07%-2.09%1.50%0.03%19.97%-8.58%-8.52%-1.95%-0.08%
Cash from Investing Activities Growth (1y) (Quarter) -108.30%62.17%91.14%-220.71%42.93%
Cash from Investing Activities (QoQ) (Quarter) -299.47%62.49%153.52%-120.72%-809.66%91.21%-628.74%90.21%
Cash from Operations Growth (1y) (Quarter) -410.25%118.21%-1,956.41%181.88%95.59%
Cash from Operations (QoQ) (Quarter) 55.35%93.76%-1,397.63%-1,123.30%101.59%-804.51%159.63%-165.88%
EBIT Growth (1y) (Quarter) -298.70%-13.37%-84.94%-45.68%1,308.33%59.17%
EBIT (QoQ) (Quarter) -626.71%23.37%67.19%-118.20%-106.65%-25.00%74.15%1,909.81%-106.98%
EBT Growth (1y) (Quarter) -298.70%-13.37%-84.94%-45.68%1,308.33%59.17%
EBT (QoQ) (Quarter) -626.71%23.37%67.19%-118.20%-106.65%-25.00%74.15%1,909.81%-106.98%
Enterprise Value Growth (1y) (Quarter) 4.64%-19.25%-11.42%-1.45%1.13%17.75%
Enterprise Value (QoQ) (Quarter) 4.07%2.09%-1.50%-0.03%-19.97%8.52%7.59%2.51%0.19%
EPS (Basic) Growth (1y) (Quarter) -400.00%-2,240.00%4,075.00%-100.00%720.00%67.52%
EPS (Basic) (QoQ) (Quarter) -400.00%20.00%75.00%-400.00%-2,240.00%235.90%-101.26%1,650.00%-222.58%
EPS (Weighted Average and Diluted) Growth (1y) (Quarter) -400.00%-2,600.00%6,050.00%-100.00%720.00%71.85%
EPS (Weighted Average and Diluted) (QoQ) (Quarter) -400.00%20.00%75.00%-400.00%-2,600.00%276.30%-100.84%1,650.00%-222.58%
Free Cash Flow Growth (1y) (Quarter) -423.57%112.57%-1,132.66%180.92%95.57%
Free Cash Flow (QoQ) (Quarter) 49.08%90.61%-773.58%-1,153.96%101.22%-1,020.68%157.35%-168.67%
Net Cash Flow Growth (1y) (Quarter) 265.53%-240.06%-148.02%287.50%-177.87%
Net Cash Flow (QoQ) (Quarter) 56.89%266.81%-203.68%322.01%-188.57%76.44%504.80%-192.20%
Net Income Growth (1y) (Quarter) -125.95%82.35%-84.94%-45.68%56.07%
Net Income (QoQ) (Quarter) -626.71%23.37%67.19%-23.66%43.25%-703.15%74.15%62.71%
Net Income towards Common Stockholders Growth (1y) (Quarter) -125.95%82.35%-84.94%-45.68%56.07%
Net Income towards Common Stockholders (QoQ) (Quarter) -626.71%23.37%67.19%-23.66%43.25%-703.15%74.15%62.71%
Profit After Tax Growth (1y) (Quarter) -298.70%-13.37%13.32%-45.68%1,308.33%59.17%
Profit After Tax (QoQ) (Quarter) -626.71%23.37%67.19%-118.20%-106.65%41.41%44.86%1,909.81%-106.98%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) -76.13%-75.79%-75.43%
Property, Plant & Equipment (Net) (QoQ) (Quarter) -11.40%-64.76%124.69%-65.48%-10.11%
Return on Assets Growth (1y) (Quarter) 0.00
Return on Assets (QoQ) (Quarter) 0.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) 17,460.00
Return on Capital Employed (QoQ) (Quarter) -26479.0033,696.0010,654.00-410.00
Return on Equity Growth (1y) (Quarter) 1.003.000.00
Return on Equity (QoQ) (Quarter) -1.002.000.000.000.000.00
Shareholder's Equity Growth (1y) (Quarter) 214.48%929.61%109.08%174.64%1,431.69%123.01%
Shareholder's Equity (QoQ) (Quarter) -352.89%434.12%-34.24%-43.41%567.14%-15.79%-13.61%215.62%-2.87%